DME Capital Management (Greenlight, David Einhorn) — LKFT Trade History
Quarter-by-quarter changes in the LAKEFRONT BIOTHERAPEUTICS NV position · CUSIP 36315X101
Currently held · 2.5 YearsFirst seen: 2024 Q1
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Hold | 482,746 | — | 0.0% | $14.5M | 0.37% |
| 2026 Q1 | 2026-05-15 | Hold | 482,746 | — | 0.0% | $14.5M | 0.45% |
| 2025 Q4 | 2026-02-17 | Hold | 482,746 | — | 0.0% | $15.8M | 0.55% |
| 2025 Q3 | 2025-11-14 | Hold | 482,746 | — | 0.0% | $16.7M | 0.66% |
| 2025 Q2 | 2025-08-14 | Hold | 482,746 | — | 0.0% | $13.5M | 0.58% |
| 2025 Q1 | 2025-05-15 | Add | 482,746 | 3,383 | +0.7% | $12.1M | 0.61% |
| 2024 Q4 | 2025-02-14 | Hold | 479,363 | — | 0.0% | $13.2M | 0.68% |
| 2024 Q3 | 2024-11-14 | Add | 479,363 | 244,535 | +104.1% | $13.8M | 0.57% |
| 2024 Q2 | 2024-08-14 | Add | 234,828 | 75,000 | +46.9% | $5.8M | 0.28% |
| 2024 Q1 | 2024-05-15 | New | 159,828 | 159,828 | — | $5.1M | 0.24% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.